Back to Search Start Over

N-acetyltransferase 2, exposure to aromatic and heterocyclic amines, and receptor-defined breast cancer

Authors :
Volker Harth
Christiane B. Pierl
Anne Spickenheuer
Caren Vollmert
Thomas Illig
Ute Hamann
Sylvia Rabstein
Yon-Dschun Ko
Christian Baisch
Tobias Weiss
Hiltrud Brauch
Christina Justenhoven
Susanne Haas
Beate Pesch
Hans-Peter Fischer
Thomas BrĂ¼ning
Source :
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 19(2)
Publication Year :
2009

Abstract

The role of N-acetyltransferase 2 (NAT2) polymorphism in breast cancer is still unclear. We explored the associations between potential sources of exposure to aromatic and heterocyclic amines (AHA), acetylation status and receptor-defined breast cancer in 1020 incident cases and 1047 population controls of the German GENICA study. Acetylation status was assessed as slow or fast. Therefore, NAT2 haplotypes were estimated using genotype information from six NAT2 polymorphisms. Most probable haplotypes served as alleles for the deduction of NAT2 acetylation status. The risks of developing estrogen receptor alpha (ER) and progesterone receptor (PR)-positive or negative tumors were estimated for tobacco smoking, consumption of red meat, grilled food, coffee, and tea, as well as expert-rated occupational exposure to AHA with logistic regression conditional on age and adjusted for potential confounders. Joint effects of these factors and NAT2 acetylation status were investigated. Frequent consumption of grilled food and coffee showed higher risks in slow acetylators for receptor-negative tumors [grilled food: ER-: odds ratio (OR) 2.57, 95% confidence interval (CI) 1.07-6.14 for regular vs. rare; coffee: ER-: OR 2.55, 95% CI 1.22-5.33 for >or=4 vs. 0 cups/day]. We observed slightly higher risks for never smokers that are fast acetylators for receptor-positive tumors compared with slow acetylators (ER-: OR 1.32, 95% CI 1.00-1.73). Our results support differing risk patterns for receptor-defined breast cancer. However, the modifying role of NAT2 for receptor-defined breast cancer is difficult to interpret in the light of complex mixtures of exposure to AHA.

Details

ISSN :
14735709
Volume :
19
Issue :
2
Database :
OpenAIRE
Journal :
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
Accession number :
edsair.doi.dedup.....f7d5af880aab16d9fee3efdd074cb958